When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, Cox V, Giddy J, Chimbetete C, Wood R, Gsponer T, Bolton Moore C, Rabie H, Eley B, Muhe L, Penazzato M, Essajee S, Keiser O, Davies MA; International Epidemiologic Databases to Evaluate AIDS–Southern Africa (IeDEA-SA) Collaboration.
Schomaker M, et al.
PLoS Med. 2013 Nov;10(11):e1001555. doi: 10.1371/journal.pmed.1001555. Epub 2013 Nov 19.
PLoS Med. 2013.
PMID: 24260029
Free PMC article.
BACKGROUND: There is limited evidence on the optimal timing of antiretroviral therapy (ART) initiation in children 2-5 y of age. We conducted a causal modelling analysis using the International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) collaborati …
BACKGROUND: There is limited evidence on the optimal timing of antiretroviral therapy (ART) initiation in children 2-5 y of age. We conducte …